Single dose pharmacokinetics of selective serotonin reuptake inhibitor sertraline in plasma of female anorexia nervosa patients and healthy volunteers after oral administration: an exploratory study

2024-512830-13-00 Human pharmacology (Phase I) - Other Ongoing, recruiting

Start 25 Mar 2019 · Status Ongoing, recruiting · 1 EU/EEA countries · 1 sites

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - Other
Status Ongoing, recruiting
Participants planned 8
Countries 1
Sites 1

anorexia nervosa

Key facts

Sponsor
Medical University Of Vienna
Participant type
Patients, Healthy volunteers
Age range
18-64 years
Gender
Female
Therapeutic area
Psychiatry and Psychology [F] - Behavior and Behavior Mechanisms [F01]
Trial duration
25 Mar 2019 → ongoing
Decision date (initial)
2024-05-21
Transition trial
Yes
Low-intervention
No
Rare-disease indication
No
Vulnerable population
No

External identifiers

EU CT number
2024-512830-13-00
EudraCT number
2019-000077-23

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

anorexia nervosa

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Medical University Of Vienna

Sponsor organisation
Medical University Of Vienna
Address
Spitalgasse 23, Alsergrund Alsergrund
City
Vienna
Postcode
1090
Country
Austria

Scientific contact point

Organisation
Medical University Of Vienna
Contact name
Department of Clinical Pharmacology

Public contact point

Organisation
Medical University Of Vienna
Contact name
Department of Clinical Pharmacology

Locations

1 EU/EEA country · 1 investigational sites

By country

CountryMS statusPlanned subjectsSites
Austria Ongoing, recruiting 8 1
Rest of world 0

Investigational sites

Austria

1 site · Ongoing, recruiting
Medical University Of Vienna
Department of Clinical Pharmacology, Waehringer Guertel 18-20, Alsergrund, Vienna

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Austria 2019-03-25 2019-03-26

Application history

1 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-04-09 Austria Acceptable with conditions
2024-05-12
2024-05-21